An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Pelacarsen (TQJ230)OngoingRecruitingPhase 3Open NCT07517263 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07517263 · Trial Tracker · ComplyRx